IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
Compound with spectra: 1 NMR
![IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE](/api/compound/39RwJuLb19W.png?ph=true&h=300&w=458 "IMPURITY-V;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-(5-HYDROXY)-PENTANOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE")
| SpectraBase Compound ID | 39RwJuLb19W |
|---|---|
| InChI | InChI=1S/C24H29N5O4/c1-16(2)22(24(32)33)29(21(31)9-5-6-14-30)15-17-10-12-18(13-11-17)19-7-3-4-8-20(19)23-25-27-28-26-23/h3-4,7-8,10-13,16,22,30H,5-6,9,14-15H2,1-2H3,(H,32,33)(H,25,26,27,28)/t22-/m0/s1 |
| InChIKey | WFTHJYXTAIPUOD-QFIPXVFZSA-N |
| Mol Weight | 451.53 g/mol |
| Molecular Formula | C24H29N5O4 |
| Exact Mass | 451.221954 g/mol |
| Enantiomer InChIKey | WFTHJYXTAIPUOD-JOCHJYFZSA-N |
| Racemate InChIKey | WFTHJYXTAIPUOD-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
IMPURITY-IV;(S)-N-(1-CARBOXY-2-METHYLPROP-1-YL)-N-4-PENTENOYL-N-[2'-(1-H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMINE
Losartan-M (HO-alkyl) isomer 1 MS3_2
2-(4'-TRIFLUOROMETHYL-BIPHENYL-2-YL)-4(5)-(4-METHOXYPHENYL)-IMIDAZOLE
(2R,3S)-1-Benzyl-3-phenylpyroglutamic acid
Ethyl 2'-(3-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxylate
2-Methyl-3-(4'-nitro-[1,1'-biphenyl]-2-yl)pyrazine
s-Triazine, 2,4-diamino-6-(2'-nitro-2-biphenylyl)-
Ethyl 5-benzyl-6-oxo-5-azaspiro[2.3]hexane-4-carboxylate
Methyl 1-(4-(5,6-dimethyl-1H-benzo[d]imidazol-2-yl)benzoyl)pyrrolidine-2-carboxylate
N-[(2,3-Dimethoxyphenyl)methyl]-5-carboxy-2-pyrrolidone
| Title | Journal or Book | Year |
|---|---|---|
| Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist | Journal of Pharmaceutical and Biomedical Analysis | 2009 |